Efficacy of granisetron for the treatment of postoperative nausea and vomiting in women undergoing breast surgery: A randomised, double-blind, placebo-controlled trial

Clinical Drug Investigation

Volumn 26, Issue 4, 2006, Pages 203-208

  Fujii, Yoshitaka ^a,b   Tanaka, Hiroyoshi ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANISETRON; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIEMETIC ACTIVITY; ARTICLE; BREAST SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE DRUG DOSE; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ANTIEMETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; GAGGING; GRANISETRON; HUMANS; INJECTIONS, INTRAVENOUS; MASTECTOMY; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; SEROTONIN ANTAGONISTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33645539576     PISSN: 11732563     EISSN: 11732563     Source Type: Journal    
DOI: 10.2165/00044011-200626040-00004     Document Type: Article

References (15)

1. Jakobsson J, Andersson L, Nilsson A, et al. Premedication before elective breast surgery, a comparison between ketobemidone and midazolam. Acta Anaesthesiol Scand 1991; 35: 524-8
2. Oddby-Muhrbeck E, Jakobsson J, Andersson L, et al. Postoperative nausea and vomiting: a comparison between intravenous and inhalation anaesthesia in breast surgery. Acta Anaesthesiol Scand 1994; 38: 52-6
3. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-84
4. McCormick CG. FDA alert: current FDA report on droperidol status and basis for 'Black Box' warning. ASA Newsl 2002; 66: 19
5. 3 receptor antagonit BRL 43694. Br J Cancer 1988; 58: 644-50
6. Fujii Y, Tanaka H, Kawasaki T. A comparison of granisetron, droperidol, metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial. Clin Ther 2003; 25: 1142-9
7. Drugs in Japan: ethical drugs 2004 (27th ed), edited by Japan Pharmaceutical Information Center, Tokyo, Japan. December 2004
8. Kranke P, Apefel C, Papenfuss T, et al. An increased body mass index is not risk factor for postoperative nausea and vomiting: a systematic review and results of original data. Acta Anaesthesiol Scand 2001; 45: 160-6
9. Ramsay TM, McDonald PF, Faragher EB. The menstrual cycle and nausea or vomiting after wisdom teeth extraction. Can J Anaesth 1994; 41: 798-801
10. Gan TG, Meyer T, Apfel C, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62-71
11. 3 receptor antagonist: correlation of anti-emetic response. Cancer Chemother Pharmacol 1989; 24: 45-9
12. Yarker YE, McTavish D. Granisetron: an update of its therapeutic use in nausea and vomiting induced by antineoplasmic therapy. Drugs 1994; 48: 761-93
13. Sadhasivam S, Saxena A, Kathirvel S, et al. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. Anesth Analg 1999; 89: 1340-5
14. Dua N, Bhatnagar S, Mishra S, et al. Granisetron and ondansetron for prevention of nausea and vomiting in patients undergoing modified radical mastectomy. Anaesth Intensive Care 2004; 32: 761-4
15. 3 receptor antagonists the same. Eur J Cancer 1992; 28A Suppl. 1: S2-6